Valneva (VALN)
(Delayed Data from NSDQ)
$7.25 USD
-0.50 (-6.45%)
Updated Jun 14, 2024 02:54 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
VALN 7.25 -0.50(-6.45%)
Will VALN be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for VALN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for VALN
Strength Seen in Valneva SE Sponsored ADR (VALN): Can Its 15.8% Jump Turn into More Strength?
Valneva (VALN) Stock Down 53% in the Past Year: Here's Why
VALN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Valneva (VALN) Stock Down 61.5% in the Past Year: Here's Why
What Makes Valneva SE Sponsored ADR (VALN) a New Buy Stock
Valneva (VALN) Up on Antibody Persistence Data on Chikungunya Jab
Other News for VALN
Valneva Announces General Meeting and Leadership Change
Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate Update
Valneva Engages Investors with Vaccine Pipeline Updates
Valneva to Present and Hold Investor Meetings at Upcoming Conferences in June
Buy Rating for Valneva’s VLA15 Vaccine on Promising Clinical Results and Market Potential